MBX BIOSCIENCES INC (MBX) Stock Analyst Ratings
USA - NASDAQ:MBX - US55287L1017 - Common Stock
20 USD
+10 (+100%)
19.03 USD
-0.97 (-4.85%)
ChartMill assigns a Buy % Consensus number of 87% to MBX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 38.47. This target is 92.34% above the current price.
MBX was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about MBX.
In the previous month the buy percentage consensus was at a similar level.
MBX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-05 | Mizuho | Initiate | Outperform |
| 2025-07-16 | Oppenheimer | Initiate | Outperform |
| 2025-04-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-10 | JMP Securities | Initiate | Market Outperform |
| 2024-10-08 | Guggenheim | Initiate | Buy |
| 2024-10-08 | Stifel | Initiate | Buy |
| 2024-10-08 | JP Morgan | Initiate | Overweight |
| 2024-10-08 | Jefferies | Initiate | Buy |